Determinants of long-term outcomes in patients with COVID-19 supported with ECMO
- PMID: 37030309
- PMCID: PMC10156141
- DOI: 10.1016/S2213-2600(23)00010-3
Determinants of long-term outcomes in patients with COVID-19 supported with ECMO
Conflict of interest statement
CG has received fees for lectures from Xenios (Fresenius Medical Care). MG contributed to the EuroECMO-COVID study as a member of the EuroECMO-COVID Study Group. MS has received fees for lectures from Getinge, Baxter, and Fresenius. NN and SH declare no competing interests.
Comment in
-
Determinants of long-term outcomes in patients with COVID-19 supported with ECMO - Authors' reply.Lancet Respir Med. 2023 May;11(5):e42. doi: 10.1016/S2213-2600(23)00134-0. Epub 2023 Apr 5. Lancet Respir Med. 2023. PMID: 37030307 Free PMC article. No abstract available.
Comment on
-
In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study.Lancet Respir Med. 2023 Feb;11(2):151-162. doi: 10.1016/S2213-2600(22)00403-9. Epub 2022 Nov 16. Lancet Respir Med. 2023. PMID: 36402148 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical